5 Firms Guide $834M Chinese Biopharma SPAC Merger
Beijing-based biopharmaceutical company Yisheng Biopharma Co. Ltd., announced on Thursday that it will merge with Hong Kong-based blank-check company Summit Healthcare Acquisition Corp. in a transaction that values the new company...To view the full article, register now.
Already a subscriber? Click here to view full article